Evidence map›Paper›PMID 32224232›Full record

ReviewThe journal of allergy and clinical immunology. In practice2020

COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.

Marcus S Shaker, John Oppenheimer, Mitchell Grayson, David Stukus, Nicholas Hartog, Elena W Y Hsieh, Nicholas Rider, Cullen M Dutmer, Timothy K Vander Leek, Harold Kim and 11 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The journal of allergy and clinical immunology. In practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 157 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Review
  7. Impact of the COVID-19 Pandemic on Adult Asthma-Related Healthcare Utilization.medRxiv : the preprint server for health sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Asthma management in the digital age.Frontiers in allergy · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Article

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Marcus S ShakerDartmouth-Hitchcock Medical Center, Section of Allergy and Immunology, Lebanon, NH; Dartmouth Geisel School of Medicine, Hanover, NH.
John OppenheimerUMDMJ Rutgers University School of Medicine, Newark, NJ.
Mitchell GraysonNationwide Children's Hospital, The Ohio State University School of Medicine, Columbus, Ohio.
David StukusNationwide Children's Hospital, The Ohio State University School of Medicine, Columbus, Ohio.
Nicholas HartogSpectrum Health Helen DeVos Children's Hospital, Grand Rapids, Mich.
Elena W Y HsiehChildren's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo.
Nicholas RiderThe Texas Children's Hospital, Section of Immunology, Allergy, and Retrovirology and the Baylor College of Medicine, Houston, Texas.
Cullen M DutmerChildren's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo.
Timothy K Vander LeekPediatric Allergy and Asthma, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.
Harold KimWestern University and McMaster University, London, ON, Canada.
Edmond S ChanBC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
Doug MackMcMaster University, Hamilton, ON, Canada; Halton Pediatric Allergy, Burlington, ON, Canada.
Anne K EllisDivision of Allergy and Immunology, Department of Medicine, Queen's University, Kingston, ON, Canada.
David LangDepartment of Medicine, Section of Allergy and Immunology, Cleveland Clinic, Cleveland, Ohio.
Jay LiebermanDivision of Allergy and Immunology, The University of Tennessee, Memphis, Tenn.
David FleischerChildren's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo.
David B K GoldenDivision of Allergy and Clinical Immunology, John Hopkins University School of Medicine, Baltimore, Md.
Dana WallaceNova Southeastern University College of Allopathic Medicine, Fort Lauderdale, Fla.
Jay PortnoyChildren's Mercy, University of Missouri-Kansas City School of Medicine, Kansas City, Mo.
Giselle MosnaimDivision of Pulmonary, Allergy and Critical Care, Department of Medicine, NorthShore University Health System, Evanston, Ill.
Matthew GreenhawtChildren's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo. Electronic address: Matthew.Greenhawt@childrenscolorado.org.

Funding

Immune Dysregulation in Pediatric SLE PathogenesisK23AR070897 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI HSIEH, WEN-YUAN E · 2017 to 2021
$850k
Determining Tradeoffs Among Health Benefits, Adverse Events, and Resource Use Associated with Food Allergy TreatmentK08HS024599 · AHRQ · UNIVERSITY OF COLORADO DENVER · PI GREENHAWT, MATTHEW JASON · 2016 to 2018
$450k
AHRQ HHS 5K08HS024599-02AHRQ HHS K08 HS024599NIAMS NIH HHS K23 AR070897
6 · The paper itself

Abstract

In the event of a global infectious pandemic, drastic measures may be needed that limit or require adjustment of ambulatory allergy services. However, no rationale for how to prioritize service shut down and patient care exists. A consensus-based ad-hoc expert panel of allergy/immunology specialists from the United States and Canada developed a service and patient prioritization schematic to temporarily triage allergy/immunology services. Recommendations and feedback were developed iteratively, using an adapted modified Delphi methodology to achieve consensus. During the ongoing pandemic while social distancing is being encouraged, most allergy/immunology care could be postponed/delayed or handled through virtual care. With the exception of many patients with primary immunodeficiency, patients on venom immunotherapy, and patients with asthma of a certain severity, there is limited need for face-to-face visits under such conditions. These suggestions are intended to help provide a logical approach to quickly adjust service to mitigate risk to both medical staff and patients. Importantly, individual community circumstances may be unique and require contextual consideration. The decision to enact any of these measures rests with the judgment of each clinician and individual health care system. Pandemics are unanticipated, and enforced social distancing/quarantining is highly unusual. This expert panel consensus document offers a prioritization rational to help guide decision making when such situations arise and an allergist/immunologist is forced to reduce services or makes the decision on his or her own to do so.

Indexed as

Allergy and ImmunologyAmbulatory Care FacilitiesCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralTelemedicineAllergic rhinitisAllergyAllergy immunotherapyAngioedemaAsthmaAtopic dermatitisCOVID-19Food allergyPrimary immunodeficiencySARS-CoV-2UrticariaVenom allergy

Identifiers

PMID32224232
PMCPMC7195089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.